Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Unknown 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 5INDUSTRY 4

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Breast Neoplasms 7227Neoplasms 4535Prostatic Neoplasms 3486Colorectal Neoplasms 2930Carcinoma, Non-Small-Cell Lung 2823Lung Neoplasms 2539Leukemia, Myeloid, Acute 1980Pancreatic Neoplasms 1870Multiple Myeloma 1805Carcinoma, Hepatocellular 1729Neoplasm Metastasis 1585Stomach Neoplasms 1498Lymphoma 1455Precursor Cell Lymphoblastic Leukemia-Lymphoma 1434Head and Neck Neoplasms 1430Brain Neoplasms 1367Melanoma 1344Ovarian Neoplasms 1339Leukemia 1301Rectal Neoplasms 1266Recurrence 1249Colonic Neoplasms 1204Glioblastoma 1133Uterine Cervical Neoplasms 1090Lymphoma, Non-Hodgkin 1064Leukemia, Lymphocytic, Chronic, B-Cell 989Esophageal Neoplasms 963Lymphoma, Follicular 936Lymphoma, Large B-Cell, Diffuse 931Squamous Cell Carcinoma of Head and Neck 920

Interventions

Leucovorin 2Irinotecan 2Fluorouracil 2spartalizumab 1camrelizumab 1Radiosurgery 1Oxaliplatin 1Oncolytic Virotherapy 1KD025 1IFL protocol 1Folfox protocol 1Drug Therapy 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × CRC × Clear all
NCT07381309 2026-04-28

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting
114 enrolled
Gastrointestinal

CRC

NCT07204574 2025-10-02

The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer

Chang Gung Memorial Hospital

Phase 1/2 Recruiting
40 enrolled

CRC

NCT05382377 2022-05-19

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

The Affiliated Hospital of the Chinese Academy of Military Medical Sciences

Phase EARLY_PHASE1 Unknown
18 enrolled
Other solid neoplasm

CRC

NCT03337776 2021-08-05

Effect of WhatsApp Messenger on Uptake of CRC Screening Study

Chinese University of Hong Kong

Phase NA Withdrawn

CRC

NCT03601598 2018-07-26

A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

Harbin Medical University

Phase 1/2 Unknown
41 enrolled
Thoracic

CRC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡